Given its established role as a pivotal modulator of inflammatory and metabolic processes in peripheral diseases, and its recent implication in ischemic stroke outcomes, we hypothesized that FABP4 might also play a critical role in mediating microglial dysfunction and neuroinflammation after ICH. This evidence concerns the gene FABP4 and ischemic stroke.